V. Collins

1.1k total citations
22 papers, 832 citations indexed

About

V. Collins is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, V. Collins has authored 22 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in V. Collins's work include Genetic Neurodegenerative Diseases (5 papers), Glycogen Storage Diseases and Myoclonus (2 papers) and Mitochondrial Function and Pathology (2 papers). V. Collins is often cited by papers focused on Genetic Neurodegenerative Diseases (5 papers), Glycogen Storage Diseases and Myoclonus (2 papers) and Mitochondrial Function and Pathology (2 papers). V. Collins collaborates with scholars based in Australia, United States and United Kingdom. V. Collins's co-authors include R. Williamson, Andrew Churchyard, Louise A. Corben, Jane Halliday, Martin B. Delatycki, Paul Zimmet, Michael Fahey, Rosemary Warren, Gary K. Dowse and Myrlene A. Staten and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Brain.

In The Last Decade

V. Collins

20 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Collins Australia 15 196 181 150 131 125 22 832
Kenneth Silver Canada 18 99 0.5× 326 1.8× 108 0.7× 55 0.4× 271 2.2× 32 1.0k
J. C. Christian United States 25 161 0.8× 514 2.8× 521 3.5× 98 0.7× 104 0.8× 52 2.0k
G.P. Hemmings United Kingdom 17 199 1.0× 404 2.2× 299 2.0× 108 0.8× 45 0.4× 44 1.2k
H. M. Schulte Germany 24 273 1.4× 214 1.2× 77 0.5× 107 0.8× 80 0.6× 55 2.1k
Douglas E. Crompton Australia 18 362 1.8× 457 2.5× 343 2.3× 101 0.8× 143 1.1× 28 1.4k
Mathias Rhein Germany 15 117 0.6× 272 1.5× 72 0.5× 53 0.4× 29 0.2× 47 644
Ilan Blatt Israel 18 229 1.2× 199 1.1× 68 0.5× 60 0.5× 166 1.3× 47 976
Louis Holdstock United States 12 335 1.7× 107 0.6× 39 0.3× 221 1.7× 26 0.2× 21 1.0k
Catherine A Johnson United States 15 235 1.2× 522 2.9× 345 2.3× 141 1.1× 97 0.8× 35 1.2k
AS Levine United States 14 249 1.3× 142 0.8× 22 0.1× 23 0.2× 48 0.4× 15 845

Countries citing papers authored by V. Collins

Since Specialization
Citations

This map shows the geographic impact of V. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Collins more than expected).

Fields of papers citing papers by V. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Collins. The network helps show where V. Collins may publish in the future.

Co-authorship network of co-authors of V. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of V. Collins. A scholar is included among the top collaborators of V. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Collins. V. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ioannou, Liane, John Massie, V. Collins, Belinda McClaren, & M. B. Delatycki. (2010). Population-Based Genetic Screening for Cystic Fibrosis: Attitudes and Outcomes. Public Health Genomics. 13(7-8). 449–456. 27 indexed citations
2.
Corben, Louise A., Geneieve Tai, Callum Wilson, et al.. (2009). A comparison of three measures of upper limb function in Friedreich ataxia. Journal of Neurology. 257(4). 518–523. 27 indexed citations
3.
Fahey, Michael, Phillip D. Cremer, S. T. Aw, et al.. (2008). Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia. Brain. 131(4). 1035–1045. 102 indexed citations
4.
Churchyard, Andrew, Lynette J. Tippett, Virginia M. Hogg, et al.. (2008). Poster 17: Lifestyle Activity and the Age of Onset of Huntington Disease. Neurotherapeutics. 6(1). 209–209.
5.
Collins, V., et al.. (2007). Newborn screening for mucopolysaccharidoses: opinions of patients and their families. Clinical Genetics. 71(5). 446–450. 28 indexed citations
6.
Fahey, Michael, Louise A. Corben, V. Collins, Andrew Churchyard, & M. B. Delatycki. (2007). The 25-foot walk velocity accurately measures real world ambulation in Friedreich ataxia. Neurology. 68(9). 705–706. 14 indexed citations
7.
Olsson, Craig A., Graham Byrnes, Richard Anney, et al.. (2007). COMT Val158Met and 5HTTLPR functional loci interact to predict persistence of anxiety across adolescence: results from the Victorian Adolescent Health Cohort Study. Genes Brain & Behavior. 6(7). 647–652. 42 indexed citations
8.
Fahey, Michael, Louise A. Corben, V. Collins, Andrew Churchyard, & Martin B. Delatycki. (2006). How is disease progress in Friedreich's ataxia best measured? A study of four rating scales. Journal of Neurology Neurosurgery & Psychiatry. 78(4). 411–413. 71 indexed citations
9.
Olsson, Craig A., Graham Byrnes, V. Collins, et al.. (2005). Association between 5-HTTLPR genotypes and persisting patterns of anxiety and alcohol use: results from a 10-year longitudinal study of adolescent mental health. Molecular Psychiatry. 10(9). 868–876. 66 indexed citations
10.
Delatycki, MB, Katrina J. Allen, Amy Nisselle, et al.. (2005). Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. The Lancet. 366(9482). 314–316. 73 indexed citations
11.
Nisselle, Amy, MB Delatycki, V. Collins, et al.. (2004). Implementation of HaemScreen, a workplace‐based genetic screening program for hemochromatosis. Clinical Genetics. 65(5). 358–367. 28 indexed citations
12.
Meiser, Bettina, V. Collins, Rosemary Warren, et al.. (2004). Psychological impact of genetic testing for hereditary non‐polyposis colorectal cancer. Clinical Genetics. 66(6). 502–511. 66 indexed citations
13.
Collins, V., Jane Halliday, Rosemary Warren, & R. Williamson. (2000). Cancer worries, risk perceptions and associations with interest in DNA testing and clinic satisfaction in a familial colorectal cancer clinic. Clinical Genetics. 58(6). 460–468. 59 indexed citations
14.
Courten, Maximilian de, Paul Zimmet, Allison Hodge, et al.. (1997). Hyperleptinaemia: the Missing Link in the Metabolic Syndrome?. Diabetic Medicine. 14(3). 200–208. 140 indexed citations
15.
Dowse, Gary K., V. Collins, Paul Zimmet, & Caroline F. Finch. (1990). Cross-sectional and longitudinal relationship between obesity, hypertension and coronary heart disease in Micronesian Nauruans. Diabetes Research and Clinical Practice. 10. S179–S183. 3 indexed citations
16.
Collins, V., Paul Zimmet, Gary K. Dowse, Caroline F. Finch, & A.W. Linnane. (1989). Performance of ‘Micro-Bumintest’ tablets for detection of microalbuminuria in Nauruans. Diabetes Research and Clinical Practice. 6(4). 271–277. 5 indexed citations
17.
King, H., Peter Heywood, Paul Zimmet, et al.. (1984). Glucose tolerance in a highland population in Papua New Guinea.. PubMed. 1(1). 45–51. 28 indexed citations
18.
19.
Collins, V., Beck Taylor, Paul Zimmet, et al.. (1984). Impaired glucose tolerance in Kiribati.. PubMed. 97(768). 809–12. 7 indexed citations
20.
Raper, Lacey, Beverley Balkau, Richard Taylor, et al.. (1983). Plasma glucose distributions in two pacific populations: The bimodality phenomenon.. The Tohoku Journal of Experimental Medicine. 141(Suppl). 199–206. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Silver Breakdown of academic impact, for papers by J. C. Christian Breakdown of academic impact, for papers by G.P. Hemmings Breakdown of academic impact, for papers by H. M. Schulte Breakdown of academic impact, for papers by Douglas E. Crompton Breakdown of academic impact, for papers by Mathias Rhein Breakdown of academic impact, for papers by Ilan Blatt Breakdown of academic impact, for papers by Louis Holdstock Breakdown of academic impact, for papers by Catherine A Johnson Breakdown of academic impact, for papers by AS Levine
Rankless by CCL
2026